Literature DB >> 34982309

Prediction of procedural success of transcatheter mitral valve repair with normal and extended clip arms.

Annemarie Kirschfink1, Mhd Nawar Alachkar2, Mohammad Almalla2, Julian Grebe2, Felix Vogt2, Jörg Schröder2, Michael Frick2, Nikolaus Marx2, Ertunc Altiok2.   

Abstract

TMVR using different clip sizes is a treatment option for selected patients with mitral regurgitation (MR). This study sought to identify predictors of successful transcatheter mitral valve repair (TMVR) by 3-dimensional (3D) echocardiography and to compare different effects of the larger XTR and the smaller NT/NTR devices. 3D transesophageal echocardiography was performed on 54 patients with secondary MR undergoing TMVR with one clip (55.6% NT/NTR, 44.4% XTR). All NT/NTR and 96% of XTR patients had MR reduction ≤ 2+. Despite more severe baseline MR (3D vena contracta area (VCA): 0.67 ± 0.34 cm2 vs. 0.43 ± 0.19 cm2, p = 0.004) and greater mitral valve area (MVA) (6.8 ± 2.1 cm2 vs. 5.1 ± 1.6 cm2, p = 0.001) in the XTR group, MR severity after TMVR was not different between XTR and NT/NTR patients (3D VCA: 0.19 ± 0.14 vs. 0.17 ± 0.10, p = 0.51). Baseline 3D VCA > 0.45 cm2 in NT/NTR (AUC = 0.802, 95% CI 0.602 to 1.000) and 3D VCA > 0.54 cm2 in XTR devices (AUC = 0.868, 95% CI 0.719 to 1.000) were associated with ineffective MR reduction defined as residual VCA ≤ 0.2 cm2. Baseline MVA ≤ 4.2 cm2 in NT/NTR (AUC = 0.920, 95% CI 0.809 to 1.000) and MVA ≤ 6.0 cm2 in XTR devices (AUC = 0.865, 95% CI 0.664 to 1.000) were associated with postprocedural transmitral pressure gradient (TMPG) ≥ 5 mmHg. TMVR using the XTR device resulted in an equally effective reduction of MR despite of a greater baseline MR. Distinct cut-off values of baseline 3D VCA and MVA for prediction of successful MR reduction and postprocedural increase of TMPG were identified for the different devices.
© 2022. The Author(s).

Entities:  

Keywords:  3-dimensional echocardiography; Secondary mitral regurgitation; Transcatheter mitral valve repair; Transesophageal echocardiography

Year:  2022        PMID: 34982309     DOI: 10.1007/s10554-021-02514-7

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  8 in total

1.  2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.

Authors:  Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodríguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; José Luis Zamorano
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2018-02

2.  The PASCAL transcatheter mitral valve repair system for the treatment of mitral regurgitation: another piece to the puzzle of edge-to-edge technique.

Authors:  Carmelo Grasso; Antonio Popolo Rubbio
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

3.  Percutaneous repair or surgery for mitral regurgitation.

Authors:  Ted Feldman; Elyse Foster; Donald D Glower; Donald G Glower; Saibal Kar; Michael J Rinaldi; Peter S Fail; Richard W Smalling; Robert Siegel; Geoffrey A Rose; Eric Engeron; Catalin Loghin; Alfredo Trento; Eric R Skipper; Tommy Fudge; George V Letsou; Joseph M Massaro; Laura Mauri
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

4.  Comprehensive echocardiographic prediction of postprocedural transmitral pressure gradient following transcatheter mitral valve repair.

Authors:  Hannes Alessandrini; Peter Wohlmuth; Felix Meincke; Samer Hakmi; Timm Ubben; Sebastian Bohnen; Theresa Wißt; Karl-Heinz Kuck; Stephan Willems; Eike Tigges
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-27       Impact factor: 2.357

5.  Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation.

Authors:  Jean-François Obadia; David Messika-Zeitoun; Guillaume Leurent; Bernard Iung; Guillaume Bonnet; Nicolas Piriou; Thierry Lefèvre; Christophe Piot; Frédéric Rouleau; Didier Carrié; Mohammed Nejjari; Patrick Ohlmann; Florence Leclercq; Christophe Saint Etienne; Emmanuel Teiger; Lionel Leroux; Nicole Karam; Nicolas Michel; Martine Gilard; Erwan Donal; Jean-Noël Trochu; Bertrand Cormier; Xavier Armoiry; Florent Boutitie; Delphine Maucort-Boulch; Cécile Barnel; Géraldine Samson; Patrice Guerin; Alec Vahanian; Nathan Mewton
Journal:  N Engl J Med       Date:  2018-08-27       Impact factor: 91.245

6.  Transcatheter Mitral-Valve Repair in Patients with Heart Failure.

Authors:  Gregg W Stone; JoAnn Lindenfeld; William T Abraham; Saibal Kar; D Scott Lim; Jacob M Mishell; Brian Whisenant; Paul A Grayburn; Michael Rinaldi; Samir R Kapadia; Vivek Rajagopal; Ian J Sarembock; Andreas Brieke; Steven O Marx; David J Cohen; Neil J Weissman; Michael J Mack
Journal:  N Engl J Med       Date:  2018-09-23       Impact factor: 91.245

7.  Analysis of procedural effects of percutaneous edge-to-edge mitral valve repair by 2D and 3D echocardiography.

Authors:  Ertunc Altiok; Sandra Hamada; Kathrin Brehmer; Kathrin Kuhr; Sebastian Reith; Michael Becker; Jörg Schröder; Mohammad Almalla; Walter Lehmacher; Nikolaus Marx; Rainer Hoffmann
Journal:  Circ Cardiovasc Imaging       Date:  2012-09-21       Impact factor: 7.792

8.  Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair.

Authors:  D Scott Lim; Matthew R Reynolds; Ted Feldman; Saibal Kar; Howard C Herrmann; Andrew Wang; Patrick L Whitlow; William A Gray; Paul Grayburn; Michael J Mack; Donald D Glower
Journal:  J Am Coll Cardiol       Date:  2013-10-31       Impact factor: 24.094

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.